Organization Profile

ProMIS Neurosciences Inc.

ProMIS Neurosciences is a TSX listed biotech company (trading symbol: PMN.TO), headquartered in Toronto, Ontario and with offices in Cambridge, Massachusetts. The mission of ProMIS is to discover and develop precision medicine therapeutics for effective treatment of...

You just read:

ProMIS Neurosciences issues white paper entitled: Critical Insight - Toxic soluble Amyloid beta oligomers ("prions"), not plaque, drive pathogenesis in Alzheimer's disease

News provided by

ProMIS Neurosciences Inc.

Oct 04, 2016, 07:00 ET